This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Safety Study of Subthalamic Nucleus Gene Therapy for Parkinson's Disease

This study has been completed.
Sponsor:
Collaborators:
Weill Medical College of Cornell University
North Shore University Hospital
Information provided by:
Neurologix, Inc.
ClinicalTrials.gov Identifier:
NCT00195143
First received: September 15, 2005
Last updated: March 26, 2008
Last verified: September 2005
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: August 2005
  Primary Completion Date: No date given
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):